Overview

The GMO Global Opportunistic Value UCITS Fund seeks to generate total return by investing primarily in developed and emerging market equities. The Fund measures its performance against the MSCI ACWI Value Index.

The Fund seeks to benefit from our Asset Allocation team’s top‑down insights into the most attractively valued segments of global equity markets, coupled with bottom-up stock selection from our Systematic Equity team. Currently, the Asset Allocation team finds “deep value” (cheapest 20%) stocks to be unusually cheap relative to their own history. This actively managed Fund concentrates exposure in the deep value segment by focusing on the global stocks that GMO’s Systematic Equity team identifies as the most undervalued, using proprietary valuation models because we believe that relying on reported financials and index definitions of value may lead investors to misjudge the opportunity.

Facts

Doc Table
Fund Inception Date February 7, 2002
Fund Total Assets as of 31/08/2026 $170mm USD
SFDR Classification Article 6

USD Class E

SEDOL 01KAE9B

Performance

Documents

Literature

Prospectus Download
Prospectus - Supplement(s) Download
Investor Rights and Redress Disclosure Download
Pan-European Country Supplement Download
Prospectus - Singapore Wrapper Download
Prospectus - UK Supplement Download
KIIDs Download
PRIIPs Download
Download All Download

Downloads

Performance Download
Portfolio Composition Download
Holdings Download
Download All Download

Commentary & Attribution

Commentary Quarterly Download
Market Review Download
Attribution - Monthly Download
Attribution - Quarterly Download
Attribution - YTD Download
Download All Download

Investor Information

Semiannual Report Download
NAVs and Distributions Download
Fair Value Hierarchy - As of 30/09/25 Download
Fair Value Hierarchy - As of 31/03/26 Download
Download All Download

Risks

Risks associated with investing in the Fund may include: (1) Market Risk - Equities: the market price of equities may decline due to factors affecting the issuer, its industries, or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares; (2) Management and Operational Risk: the risk that GMO's investment techniques will fail to produce desired results, including annualized returns and annualized volatility; and (3) Non-U.S. Investment Risk: the market prices of many non-U.S. securities (particularly of companies tied economically to emerging countries) fluctuate more than those of U.S. securities. Many non-U.S. markets (particularly emerging markets) are less stable, smaller, less liquid, and less regulated than U.S. markets, and the cost of trading in those markets often is higher than it is in U.S. markets. For a more complete discussion of these and other risks, please consult the Fund's Prospectus.

Disclosures

The making available of any document on this website does not constitute a promotion, offer or sale of any securities, financial instruments, or other financial products to the public in or into any jurisdiction where such promotion, offer or sale is prohibited or to any person or class of person to whom such securities or financial instruments may not be lawfully promoted, offered or sold. You should not rely on any document on this website in making any decision to engage in investment activity without seeking further information from GMO to enable GMO to determine whether you may be eligible to receive such further information or purchase or subscribe for any securities or other financial instruments.

This product is based overseas and is not subject to the UK sustainable investment labelling and disclosure requirements. Please refer to the UK Financial Conduct Authority webpage for more information: https://www.fca.org.uk/consumers/sustainable-investment-labels-greenwashing